MitoSyne D3 + K2 — Vitamin D3 + Vitamin K2 MK-7, 50 + 90 mcg
$28.00 USD

Formula overview
A concentrated EPA + DHA softgel product built around disclosed fatty-acid amounts, oxidation limits and contaminant control rather than a vague milligram figure for total fish oil.
| Component | Role | Amount | Specification |
|---|---|---|---|
| Active | EPA + DHA Omega-3 | 1,100 mg | Re-esterified triglyceride or natural triglyceride fish oil concentrate delivering EPA 650 mg + DHA 450 mg per serving |
| Capsule / softgel shell | Two large enteric or delayed-release softgels | Per unit | Must match final allergen/vegan statement |
| Mixed tocopherols | Processing excipient | q.s.; minimum validated amount | Antioxidant protection for the oil |
| Softgel shell ingredients | Processing excipient | q.s.; minimum validated amount | Gelatin/glycerin/water or validated vegetarian alternative |
| Enteric polymer if used | Processing excipient | q.s.; minimum validated amount | Only if dissolution and label language are validated |
Active form
Re-esterified triglyceride or natural triglyceride fish oil concentrate delivering EPA 650 mg + DHA 450 mg per serving
The front label leads with EPA + DHA, not '2,000 mg fish oil.' Each batch is held to explicit PV, p-anisidine and TOTOX limits and pollutant testing.
Intended role
Support normal heart function and provide a meaningful daily amount of long-chain omega-3 fatty acids.
Evidence is extensive but not uniform. Some meta-analyses report modest cardiovascular effects, while Cochrane reviews find little or no effect on mortality in broad prevention. Supplemental omega-3 can increase atrial-fibrillation risk in a dose-dependent manner in some high-risk populations.
Interactions
Review with anticoagulants, antiplatelet medicines, bleeding disorders, atrial fibrillation, surgery or high-dose prescription omega-3 use.
The oil volume required to deliver 1,100 mg of EPA + DHA cannot fit reliably into one standard softgel.
TOTOX combines primary and secondary oxidation measures. It is one indicator of oil freshness, not a complete quality assessment.
High-quality oil, stable packaging and taking it with food reduce risk, but no product can guarantee zero aftertaste for every person.
Evidence is mixed and population-specific. The product must not be marketed as preventing or treating cardiovascular disease.
Professional review is appropriate because of bleeding and medicine considerations.